unknown
Stage
About
YolTech develops a new generation of mRNA-based gene editing therapeutics, focusing on in vivo gene editing to treat both rare and common diseases.
Explore YolTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.